Original Article

Subject Categories: Keratinocytes/Epidermis

Journal of Investigative Dermatology (2002) 119, 1261–1268; doi:10.1046/j.1523-1747.2002.19611.x

bold beta-Adrenergic Receptor Activation Inhibits Keratinocyte Migration via a Cyclic Adenosine Monophosphate-independent Mechanism

Jin Chen1, Brian B Hoffman and R Rivkah Isseroff*

  1. Department of Medicine, Stanford University School of Medicine, and VA Palo Alto Health Care System, Palo Alto, CA, U.S.A.
  2. *Department of Dermatology, University of California Davis, School of Medicine, CA, 95616, U.S.A.

Correspondence: Rivkah Isseroff, MD, Department of Dermatology, Dermatology Research, TB 192, One Shields Avenue, University of California Davis School of Medicine, Davis, CA 95616, U.S.A. Email: rrisseroff@ucdavis.edu

1Present address: FDA/CDER, HFD-160, 5600 Fishers Lane, Rockville, Maryland

Received 6 December 2001; Revised 24 June 2002; Accepted 8 August 2002.

Top

Abstract

There is increasing evidence that G-protein-coupled receptors cross-talk with growth factor receptor-mediated signal transduction in a variety of cell types. We have investigated mechanisms by which the activation of beta-adrenergic receptors, classically GTP-binding proteins coupled receptors, influence the migration of cultured human keratinocytes. We found that iso-proterenol, a beta-adrenergic receptor-selective agonist, inhibited cell migration stimulated by either epidermal growth factor, or extracellular Ca2+ in a concentration-dependent manner. This was prevented by pretreatment of the cells with the beta-adrenergic receptor-selective antagonist timolol. Interestingly, isoproterenol, at a concentration of 1 nM, did not measurably increase intracellular cyclic adenosine monophosphate concentrations yet inhibited cell migration by 50%. To test further if isoproterenol's actions were mediated via activation of adenylyl cyclase, two inhibitors of its activity, 2'5'-dideoxyadenosine and SQ22536, were used. Both compounds significantly diminished iso-proterenol-induced increases in intracellular cyclic adenosine monophosphate concentrations but did not attenuate isoproterenol-induced inhibition of cell migration. Also, forskolin (1 muM) markedly increased intracellular cyclic adenosine monophosphate concentrations but did not significantly inhibit cell migration. As mitogen-activated protein kinases are known to signal growth factor-stimulated cell migration, we examined whether beta-adrenergic receptor-mediated inhibition of keratinocyte migration might occur via inactivation of mitogen-activated protein kinases. We found that isoproterenol inhibited phosphorylation of extracellular signal-regulated kinase mitogen-activated protein kinase in a concentration-dependent manner but had no effect on the phosphorylation of the stress mitogen-activated protein kinases c-jun N-terminal kinase and stress-activated protein kinase-2. Neither forskolin nor a membrane permeable cyclic adenosine monophosphate analog inhibited phosphorylation of any of these mitogen-activated protein kinases. These findings suggest that beta-adrenergic receptor-induced inhibition of keratinocyte migration is mediated through inhibition of the extracellular signal-regulated kinase mitogen-activated protein kinase signaling in a cyclic adenosine monophosphate-independent manner.

Keywords:

cell motility, isoproterenol, wound healing

Abbreviations:

DDA, 2',5'-dideoxyadenosine; GPCR, G-protein-coupled receptor; MAP kinase, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; phospho-ERK, phosphorylated ERK; phospho-p38, phosphorylated stress-activated protein kinase-2; HKGS, human keratinocyte growth supplement

Extra navigation

.
ADVERTISEMENT